CHEMOTHERAPY LATEST EXAM PREP
QUESTIONS AND ANSWERS PDF 2026
▶ Type IV HSR. Answer: -pneumonitis
-mucositis
-contact dermatitis
-granulomas
-Graph vs host disease
▶ Lesson 7: Cumulative Dose. Answer:
▶ Cumulative dose. Answer: total amount of one antineoplastic agent
given to the pt, adding up each time that the pt has received it
▶ Cumulative lifetime dose. Answer: -"cumulative dose should not
exceed..."
-total amount of specific antineoplastic agents that can be safely given over
the course of a pt's lifetime
▶ Extravasation. Answer: -leak of a drug capable of causing tissue
damage from the vessel in which it is being administered into the surround
tissue
, ▶ Irritant. Answer: -causes inflammation, pain, and burning but rarely
causes tissue necrosis
▶ Vesicants. Answer: -causes blistering and significant pain and tissue
damage and destruction, leading to tissue death
▶ Vesicants in PIVs. Answer: -Do not use IV in hand, wrist, AC areas
-Do NOT place the IV below a recent ventipuncture site used (<24 hours)
-Use a flexible IV catheter
▶ When a vesicant extravasation occurs or is suspected, take the following
steps:. Answer: 1. Immediately STOP administering the vesicant and IV
fluids
2. Disconnect the IV tubing from the IV device. Do not remove the IV
device or noncoring port needle
3. Attempt to aspirate residual vesicant from the IV device or port needling
use a small (1-3 mL) syringe
4. Remove the peripheral IV device or port needle
5. Initiate appropriate management measures
QUESTIONS AND ANSWERS PDF 2026
▶ Type IV HSR. Answer: -pneumonitis
-mucositis
-contact dermatitis
-granulomas
-Graph vs host disease
▶ Lesson 7: Cumulative Dose. Answer:
▶ Cumulative dose. Answer: total amount of one antineoplastic agent
given to the pt, adding up each time that the pt has received it
▶ Cumulative lifetime dose. Answer: -"cumulative dose should not
exceed..."
-total amount of specific antineoplastic agents that can be safely given over
the course of a pt's lifetime
▶ Extravasation. Answer: -leak of a drug capable of causing tissue
damage from the vessel in which it is being administered into the surround
tissue
, ▶ Irritant. Answer: -causes inflammation, pain, and burning but rarely
causes tissue necrosis
▶ Vesicants. Answer: -causes blistering and significant pain and tissue
damage and destruction, leading to tissue death
▶ Vesicants in PIVs. Answer: -Do not use IV in hand, wrist, AC areas
-Do NOT place the IV below a recent ventipuncture site used (<24 hours)
-Use a flexible IV catheter
▶ When a vesicant extravasation occurs or is suspected, take the following
steps:. Answer: 1. Immediately STOP administering the vesicant and IV
fluids
2. Disconnect the IV tubing from the IV device. Do not remove the IV
device or noncoring port needle
3. Attempt to aspirate residual vesicant from the IV device or port needling
use a small (1-3 mL) syringe
4. Remove the peripheral IV device or port needle
5. Initiate appropriate management measures
